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RESULTS TO DATE: The project, "Reduction of U(VI) and toxic metals by Desulfovibrio cytochrome c3," 
is designed to obtain spectroscopic information for or against a functional interaction of cytochrome c3 
and uranium in the whole cells. That is, is the cytochrome c3 the uranium reductase? Our approach has 
been to start with purified cytochrome and determine any unique spectral disturbances during electron 
flow to U(VI). Then we will attempt to identify these signals emanating from cells actively reducing 
uranium. This project is being carried out in collaboration with Dr. William Woodruff at the Los Alamos 
National Laboratory where the spectral experiments are being carried out.    
We at the University of Missouri are preparing purified cytochrome c3 for the experiments. We have a 
procedure that appears to give >90-95% purity of this cytochrome from periplasmic extracts of 
Desulfovibrio desulfuricans strain G20. Our yields are in the range of 0.14-0.16 mg/l cell culture. These 
small batches of pure protein are being used for the baseline experiments.    
We have contacted the Protein Core Facility of the University of Missouri to set up crystallization trials for 
this cytochrome. Crystal structures of several c-type cytochromes have been published. Therefore, we 
anticipate reasonable progress in obtaining the structure of this protein from strain G20. From this 
information a more informed approach to site-directed mutagenesis of important residues will be possible. 
In addition, the crystallization of candidate mutants can be compared to that of the wild-type protein to 
determine subtle structural alterations resulting from the mutations.    
Production of the cytochrome and any mutant proteins generated in the future can be made more efficient 
by cloning of the genes into a protein expression vector that may be used either in Escherichia coli or 
Desulfovibrio. We have obtained a candidate expression vector from IBA GmbH, Gottingen, Germany, 
and are attempting to subclone the wild-type gene. Several features of the expression vector will need to 
be tested in the sulfate-reducing bacteria to allow it to be usefully applied in these bacteria. A replicon 
conferring stability in the sulfate reducers will be added to the vector as well.    
A deletion of the wild-type gene for cytochrome c3 is being constructed so that recombinant cytochrome 
c3 can be produced without contamination of the wild-type protein. A mutagenic construct has been made 
with 0.9 kb upstream and 1.1 kb downstream of the gene flanking a kanamycin resistance cassette. This 
construct has been introduced into the strain G20 and kanamycin resistance selected. The single 
recombination events that have inserted the plasmid are now being characterized before proceeding to 
the screen for the second event that will delete the gene and the plasmid from the cells.   
DELIVERABLES: No papers have resulted from this project to date. 
 
